Characterizing recombinant protein and its fragmentation by top-down mass spectrometry

IF 3.1 3区 医学 Q2 CHEMISTRY, ANALYTICAL
Zhen Long , Dening Pei , Xiang Zhu , Weijing Liu , Xi Luo , Wenhong Fan , Lei Tao
{"title":"Characterizing recombinant protein and its fragmentation by top-down mass spectrometry","authors":"Zhen Long ,&nbsp;Dening Pei ,&nbsp;Xiang Zhu ,&nbsp;Weijing Liu ,&nbsp;Xi Luo ,&nbsp;Wenhong Fan ,&nbsp;Lei Tao","doi":"10.1016/j.jpba.2025.117157","DOIUrl":null,"url":null,"abstract":"<div><div>This study establishes a top-down mass spectrometry method for evaluating the structural integrity and fragmentation profiles of recombinant proteins. Three representative samples were analyzed: recombinant collagen 1 (RC1, 15.037 kDa; no disulfide bonds), recombinant collagen 2 (RC2, 49.859 kDa; no disulfide bonds), and interferon α2b (19.497 kDa; two disulfide bonds). Both targeted MS²-based, and data-dependent acquisition (DDA)-based top-down workflows were established to accommodate different analytical needs. The developed top-down strategies enabled direct sequencing of proteins with highly repetitive sequences, which pose challenges for bottom-up methods. The findings of this study provide insights into the identification of proteins with molecular weights (MWs) below 50 kDa. First, for proteins with MWs below 12 kDa, DDA-based top-down analysis utilizing HCD fragmentation provides high-throughput identification with 50 % (eg. of 27 fragments for protein RC1). Second, for proteins with MWs greater than 12 kDa, target-MS<sup>2</sup>-based top-down approaches improve sequence coverage, achieving up to 49.5 % for RC2 by combining three dissociation strategies. Third, for proteins containing disulfide bonds, disulfide reduce pretreatment prior to MS analysis is necessary to achieve improved residue cleavage coverage. Overall, this work demonstrates that top-down mass spectrometry provides complementary data to bottom-up methods, delivering crucial insights for comprehensive characterization of therapeutic recombinant proteins.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"267 ","pages":"Article 117157"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0731708525004984","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

This study establishes a top-down mass spectrometry method for evaluating the structural integrity and fragmentation profiles of recombinant proteins. Three representative samples were analyzed: recombinant collagen 1 (RC1, 15.037 kDa; no disulfide bonds), recombinant collagen 2 (RC2, 49.859 kDa; no disulfide bonds), and interferon α2b (19.497 kDa; two disulfide bonds). Both targeted MS²-based, and data-dependent acquisition (DDA)-based top-down workflows were established to accommodate different analytical needs. The developed top-down strategies enabled direct sequencing of proteins with highly repetitive sequences, which pose challenges for bottom-up methods. The findings of this study provide insights into the identification of proteins with molecular weights (MWs) below 50 kDa. First, for proteins with MWs below 12 kDa, DDA-based top-down analysis utilizing HCD fragmentation provides high-throughput identification with 50 % (eg. of 27 fragments for protein RC1). Second, for proteins with MWs greater than 12 kDa, target-MS2-based top-down approaches improve sequence coverage, achieving up to 49.5 % for RC2 by combining three dissociation strategies. Third, for proteins containing disulfide bonds, disulfide reduce pretreatment prior to MS analysis is necessary to achieve improved residue cleavage coverage. Overall, this work demonstrates that top-down mass spectrometry provides complementary data to bottom-up methods, delivering crucial insights for comprehensive characterization of therapeutic recombinant proteins.
自上而下质谱法表征重组蛋白及其片段化
本研究建立了一种自上而下的质谱法来评估重组蛋白的结构完整性和片段谱。分析三个代表性样品:重组胶原1 (RC1, 15.037 kDa,无二硫键)、重组胶原2 (RC2, 49.859 kDa,无二硫键)和干扰素α2b(19.497 kDa, 2个二硫键)。建立了基于MS²和基于数据依赖采集(DDA)的自上而下的工作流程,以适应不同的分析需求。开发的自顶向下的策略使具有高度重复序列的蛋白质直接测序成为可能,这对自底向上的方法提出了挑战。这项研究的发现为分子量(MWs)低于50 kDa的蛋白质鉴定提供了见解。首先,对于分子量低于12 kDa的蛋白质,基于dda的自上而下分析利用HCD片段提供了高通量鉴定,鉴定率为50% %(例如。蛋白RC1的27个片段)。其次,对于分子量大于12 kDa的蛋白质,基于目标ms2的自顶向下方法提高了序列覆盖率,通过结合三种解离策略,RC2的序列覆盖率高达49.5 %。第三,对于含有二硫键的蛋白质,在质谱分析之前,二硫还原预处理是提高残基切割覆盖率的必要条件。总的来说,这项工作表明,自上而下的质谱法为自下而上的方法提供了补充数据,为治疗性重组蛋白的全面表征提供了重要的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.70
自引率
5.90%
发文量
588
审稿时长
37 days
期刊介绍: This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome. Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信